What is the best approach to manage a patient with suspected substance abuse?

Managing Suspected Substance Abuse in Primary Care

The best approach to managing suspected substance abuse begins with universal screening using a single-question tool, followed by risk stratification into hazardous use, substance abuse, or substance dependence, with each category requiring progressively more intensive interventions ranging from brief counseling to specialty referral with pharmacotherapy. 1

Initial Screening Strategy

• Use the single-question screen: "How many times in the past year have you used an illegal drug or used a prescription medication for nonmedical reasons?" as your initial assessment tool, which demonstrates 90-100% sensitivity and 74% specificity for substance use disorders 1
• Any response of 1 or more times is considered a positive screen and requires further evaluation 1
• Screen annually in established patients as part of routine care 1
• If the single-question screen is positive, administer the Drug Abuse Screening Test-10 (DAST-10) to quantify risk level, with scores of 0 indicating low risk, 1-3 indicating moderate risk, and >3 indicating substance abuse or dependence 1

Risk Stratification and Management Algorithm

Hazardous Use (Infrequent use with potential consequences)

• Provide brief counseling using motivational interviewing techniques that focus on eliciting the patient's own reasons for change rather than confronting or pushing them 2
• Conduct ongoing assessment at follow-up visits 2
• Recognize that not all substances carry equal risk—heroin, methamphetamine, and crack cocaine are intrinsically high-risk substances requiring more aggressive intervention 2, 1

Substance Abuse (One or more DSM criteria met)

Diagnostic criteria include: 2

• Recurrent use causing failure to fulfill major role obligations at work, school, or home
• Recurrent use in physically hazardous situations (e.g., driving while impaired)
• Recurrent substance-related legal problems
• Continued use despite persistent social or interpersonal problems

Management approach: 2

• Provide brief counseling and negotiate a specific plan for change using motivational interviewing principles 2
• Advise abstinence as the primary goal, but if the patient is not committed to abstinence, harm reduction strategies are appropriate (e.g., clean needles, not driving while intoxicated) 2
• Schedule close follow-up visits to monitor progress 2
• If the patient agrees to cut back or quit but is unable to do so, this indicates progression to substance dependence and requires escalation of care 2

Substance Dependence (Three or more DSM criteria met)

Diagnostic criteria include: 2

• Tolerance (need for increased amounts or diminished effect)
• Withdrawal symptoms or using to avoid withdrawal
• Using larger amounts or for longer than intended
• Persistent desire or unsuccessful efforts to cut down
• Significant time spent obtaining, using, or recovering from the substance
• Important activities given up because of substance use
• Continued use despite knowledge of physical or psychological problems caused by the substance

Management approach: 2

• Provide brief counseling and immediately refer for specialty treatment 2
• Consider pharmacotherapy with medication-assisted treatment, preferably buprenorphine or methadone maintenance therapy combined with behavioral therapies for opioid use disorder 3, 4
• Recognize that substance dependence is a chronic relapsing and remitting illness requiring a longitudinal, chronic care approach 2
• Provide ongoing assessment and support even after referral 2

Special Considerations for Opioid Use Disorder

• For patients with confirmed opioid use disorder, offer or arrange evidence-based medication-assisted treatment with buprenorphine or methadone combined with behavioral therapies 3
• Outpatient maintenance and detoxification treatment with methadone may only be provided by Opioid Treatment Programs (OTPs) certified by SAMHSA and registered by the DEA 4
• For patients already on opioid agonist therapy (OAT) who present with acute pain, never discontinue their maintenance therapy—instead, continue the usual OAT dose and provide additional short-acting opioid analgesics at higher doses and shorter intervals due to cross-tolerance 3

Critical Pitfalls to Avoid

• Never allow concerns about being manipulated to cloud clinical judgment about legitimate medical needs—apparent "drug-seeking" behavior often represents pseudoaddiction from undertreated pain, therapeutic dependence, or anxiety about symptom recurrence 3
• Avoid confronting or pushing patients to change, as this decreases motivation for change—instead, use empathetic motivational interviewing techniques 2
• Do not rush to label patients as having substance dependence without meeting the full diagnostic criteria, as this can lead to inappropriate treatment intensity 2
• Routine urine drug testing is not recommended for screening purposes but can be used selectively to support a suspected diagnosis, assess for polysubstance use, or monitor treatment response 1

Comorbidity Assessment

• Screen for mental illness and intimate partner violence, which are common in patients with substance use disorders and require concurrent management 1, 3
• Assess for infectious disease risks including HIV, hepatitis, sexually transmitted diseases, and tuberculosis in persons who use drugs illicitly 3